Topical bioavailability of triamcinolone acetonide: Effect of dose and application frequency

Archives of Dermatological Research

Volumn 298, Issue 5, 2006, Pages 221-230

  Pellanda, Carolina ^a   Ottiker, Evelyne ^b   Strub, Christoph ^a   Figueiredo, Verena ^a   Rufli, Theo ^a   Imanidis, Georgios ^b   Surber, Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Application frequency; Reservoir; Tape stripping; Topical bioavailability; Triamcinolone acetonide

Indexed keywords

ACETONE; CORTICOSTEROID; TRIAMCINOLONE ACETONIDE;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG PENETRATION; DRUG USE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IN VIVO STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SKIN CELL; STRATUM CORNEUM; ULTRAVIOLET SPECTROSCOPY;

ADHESIVES; ADMINISTRATION, TOPICAL; ADULT; EPIDERMIS; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; TRIAMCINOLONE ACETONIDE;

EID: 33748687396     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-006-0677-x     Document Type: Article

References (30)

1. Aalto-Korte K, Turpeinen M (1995) Pharmacokinetics of topical hydrocortisone at plasma level after applications once or twice daily in patients with widespread dermatitis. Br J Dermatol 133(2):259-263
2. Anissimov YG, Roberts MS (2001) Diffusion modeling of percutaneous absorption kinetics: 2. Finite vehicle volume and solvent deposited solids. J Pharm Sci 90(4):504-520
3. Borsadia S, Ghanem AH, Seta Y, Higuchi WI, Flynn GL, Behl CR, Shah VP (1992) Factors to be considered in the evaluation of bioavailability and bioequivalence of topical formulations. Skin Pharmacol 5(3):129-145
4. Bucks DA, Maibach HI, Guy RH (1985) Percutaneous absorption of steroids: effect of repeated application. J Pharm Sci 74(12):1337-1339
5. Cross SE, Magnusson BM, Winckle G, Anissimov Y, Roberts MS (2003) Determination of the effect of lipophilicity on the in vitro permeability and tissue reservoir characteristics of topically applied solutes in human skin layers. J Invest Dermatol 120(5):759-764
6. Drake LA, Dinehart SM, Farmer ER (1996) Guidelines of care for the use of topical glucocorticoids. J Am Acad Dermatol 35(4):615-619
7. Green C, Colquitt JL, Kirby J, Davidson P, Payne E (2004) Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation. Health Technol Assess 8(47):1-134
8. ICH (1994) Harmonised tripartite guideline Q2(R1) - Validation of analytical procedures: text and methodology
9. Jacobi U, Meykadeh N, Sterry W, Lademann J (2003) Effect of the vehicle on the amount of stratum corneum removed by tape stripping. J Deut Dermatol Gesell 1(11):884-889
10. Kalia YN, Alberti I, Naik A, Guy RH (2001) Assessment of topical bioavailability in vivo: the importance of stratum corneum thickness. Skin Pharmacol Physiol 14(Suppl. 1):82-86
11. Melendres JL, Bucks DA, Camel E, Wester RC, Maibach HI (1992) In vivo percutaneous absorption of hydrocortisone: multiple-application dosing in man. Pharm Res 9(9):1164-1167
12. Neelissen JA, Arth C, Wolff M, Schrijvers AH, Junginger HE, Bodde HE (2000) Visualization of percutaneous 3H-estradiol and 3H-norethindrone acetate transport across human epidermis as a function of time. Acta Derm Venereol Suppl (Stockh) 208:36-43
13. Reddy MB, Stinchcomb AL, Guy RH, Bunge AL (2002) Determining dermal absorption parameters in vivo from tape strip data. Pharm Res 19(3):292-298
14. Ritschel WA, Panchagnula R, Stemmer K, Ashraf M (1991) Development of an intracutaneous depot for drugs. Binding, drug accumulation and retention studies, and mechanism of depot. Skin Pharmacol 4(4):235-245
15. Roberts MS, Cross SE, Anissimov YG (2004) Factors affecting the formation of a skin reservoir for topically applied solutes. Skin Pharmacol Physiol 17(1):3-16
16. Scheuplein RJ, Ross LW (1974) Mechanism of percutaneous absorption. V. Percutaneous absorption of solvent deposited solids. J Invest Dermatol 62(4):353-360
17. Shah VP, Flynn GL, Yacobi A, Maibach HI, Bon C, Fleischer NM, Franz TJ, Kaplan SA, Kawamoto J, Lesko LJ, Marty JP, Pershing LK, Schaefer H, Sequeira JA, Shrivastava SP, Wilkin J, Williams RL (1998) Bioequivalence of topical dermatological dosage forms - Methods of evaluation of bioequivalence. Pharm Res 15(2):167-171
18. Stinchcomb AL, Pirot F, Touraille GD, Bunge AL, Guy RH (1999) Chemical uptake into human stratum corneum in vivo from volatile and non-volatile solvents. Pharm Res 16(8):1288-1293
19. Surber C, Schwarb FP, Smith EW (2005) Tape-stripping technique. In: Bronaugh RL, Maibach HI (eds) Percutaneous absorption. Drugs-cosmetics- mechanisms-methodology. Taylor and Francis, Boca Raton, pp 399-410
20. Taeuber U, Matthes H (1992) Percutaneous absorption of methylprednisolone aceponate after single and multiple dermal application as ointment in male volunteers. Arzneim-Forsch/Drug Res 42(9):1122-1124
21. Trampisch HJ, Windeler J, Ehle B, Lange S (2000) Trennschärfe statistischer Tests. In: Trampisch HJ, Windeler J (eds) Medizinische Statistik. Springer, Berlin Heildelberg New York, pp 223-233
22. Vickers CF (1963) Existence of reservoir in the stratum corneum: experimental proof. Arch Dermatol 88:20-23
23. Walter K, Kurz H (1988) Binding of drugs to human skin: influencing factors and the role of tissue lipids. J Pharm Pharmacol 40(10):689-693
24. Weigmann H-J, Lindemann U, Antoniou C, Tsikrikas GN, Stratigos AI, Katsambas A, Sterry W, Lademann J (2003) UV/VIS absorbance allows rapid, accurate, and reproducible mass determination of corneocytes removed by tape stripping. Skin Pharmacol Appl Skin Physiol 16(4):217-227
25. Weigmann H, Lademann J, v Pelchrzim R, Sterry W, Hagemeister T, Molzahn R, Schaefer M, Lindscheid M, Schaefer H, Shah VP (1999) Bioavailability of clobetasol propionate-quantification of drug concentrations in the stratum corneum by dermatopharmacokinetics using tape stripping. Skin Pharmacol Appl Skin Physiol 12(1-2):46-53
26. Weigmann HJ, Jacobi U, Antoniou C, Tsikrikas GN, Wendel V, Rapp C, Gers-Barlag H, Sterry W, Lademann J (2005) Determination of penetration profiles of topically applied substances by means of tape stripping and optical spectroscopy: UV filter substance in sunscreens. J Biomed Opt 10(1):140091-140097
27. Wester RC, Noonan PK, Maibach HI (1977) Frequency of application on percutaneous absorption of hydrocortisone. Arch Dermatol 113(5):620-622
28. Wester RC, Maibach H (2005) Effect of single versus multiple dosing in percutaneous absorption. In: Bronaugh RL, Maibach H (eds) Percutaneous absorption: Drugs-Cosmetics-Mechanisms-Methodology. Taylor and Francis, Boca Raton, pp 449-457
29. Wester RC, Maibach H (2005) Dermal decontamination and percutaneous absorption. In: Bronaugh RL, Maibach H (eds) Percutaneous absorption: Drugs-cosmetics-mechanisms-methodology. Taylor and Francis, Boca Raton, pp 277-289
30. Wester RC, Maibach H (2005) Interrelationsship in the dose-response of percutaneous absorption. In: Bronaugh RL, Maibach H (eds) Percutaneous absorption: Drugs-cosmetics-mechanisms-methodology. Taylor and Francis, Boca Raton, pp 317-329